Tel : 0086-021-5165-9050 / 0086-15618223367 Email : sales@atkchmemical.com
GSK1904529A
ATK-18126
98.00%
1089283-49-7
C51H58F2N7O5
887.0469
Article number Size Operate
ATK-18126 10MG 10MG Inquiry
ATK-18126 20MG 20MG Inquiry
Detection information
Purity: 99.99%
Product Details
CAS Number 1089283-49-7 Appearance
Catalog NO ATK-18126 MDL Number
Molecular Formula C51H58F2N7O5 Molecular Weight 887.0469
Boiling Point Melting Point
Flash Poin Density 1.39
Synonyms gsk1904529A;GSK-1904529A;N-(2,6-difluorophenyl)-5-[3-[2-[5-ethyl-2-methoxy-4-[4-(4-methylsulfonylpiperazin-1-yl)piperidin-1-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]-2-methoxybenzamide;GSK 4529;N-(2,6-Difluorophenyl)-5-[3-[2-[[5-ethyl-2-(methyloxy)-4-[4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl]phenyl]amino]-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl]-2-(methyloxy)benzamide;[4-[2-[3-[2-(2,6-Difluorophenyl)prop-2-enoyl]-4-methoxyphenyl]-1,7,8,8a-tetrahydroimidazo[1,2-a]pyri;GSK 1904529A;HMS3295G13;GSK1904529A;N-(2,6-difluorophenyl)-5-(3-(2-((5-ethyl-2-methoxy-4-(4-(4-(methylsulfonyl)piperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)imidazo[1,2-a]pyridin-2-yl)-2-methoxybenzamide;BRD-K04833372-001-01-3;CHEMBL466397;N-(2,6-difluorophenyl)-5-(3-(2-(5-ethyl-2-methoxy-4-(4-(4-(methylsulfonyl)piperazin-1-yl)piperidin-1-yl)phenylamino)pyrimidin-4-yl)imidazo[1,2-a]pyridin-2-yl)-2-methoxybenzamide;GSK 1904529A (GSK 4529);N-(2,6-Difluorophenyl)-5-{3-[2-(5-ethyl-4-{4-[4-(methanesulfonyl)piperazin-1-yl]piperidin-1-yl}-2-methoxyanilino)pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl}-2-methoxybenzamide;GSK1904529;NCGC00253439-01;DTXSID70648776;N-(2,6-Difluorophenyl)-5-[3-[2-[[5-ethyl-2-(methyloxy)-4-[4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl]phenyl]amino]-4-pyrimidinyl]imidazo[1,2-a]pyridin-;CHEBI:91401;AS-17030;HY-10524;CCG-264817;s1093;MOSKATHMXWSZTQ-UHFFFAOYSA-N;N-(2,6-difluorophenyl)-5-{3-[2-({5-ethyl-4-[4-(4-methanesulfonylpiperazin-1-yl)piperidin-1-yl]-2-methoxyphenyl}amino)pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl}-2-methoxybenzamide;AKOS030238962;1089283-49-7;IGF-1R inhibitor GS1904529A;HMS3654G19;MLS006010966;N-(2,6-difluorophenyl)-5-(3-{2-[(5-ethyl-2-(methyloxy)-4-{4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)-2-(methyloxy)benzamide;AC-28459;NSC767951;J-522846;GSK 4529; N-(2,6-Difluorophenyl)-5-[3-[2-[[5-ethyl-2-(methyloxy)-4-[4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl]phenyl]amino]-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl]-2-(methyloxy)benzamide;SCHEMBL309890;BRD-K04833372-001-06-2;SB19376;Q27163259;EX-A008;N-(2,6-difluorophenyl)-5-[3-[2-[5-ethyl-2-methoxy-4-[4-(4-methylsulfonyl-1-piperazinyl)-1-piperidinyl]anilino]-4-pyrimidinyl]-2-imidazo[1,2-a]pyridinyl]-2-methoxybenzamide;MFCD17010271;BDBM50256480;NSC-767951;EX-8674;SMR004702770;SDCCGSBI-0654441.P001;N-(2,6-Difluorophenyl)-5-[3-[2-[[5-ethyl-2-(methyloxy)-4-[4-[4-(methylsulfonyl)-1-piperazinyl]-1-Piperidinyl]phenyl]amino]-4-pyrimid inyl]imidazo[1,2-a]pyridin-2-yl]-2-(methyloxy)benzamide;SW219610-1;NCGC00253439-04
Storage Condition
Safety
GHS Pictogram
Signal Word UN Number
Hazard Statements Class
Precautionary Statements Packing Group
Description
There is currently no product overview available!